VIS-101, purpose-designed to be best-in-class for retinal vascular diseases, is a tetravalent, dual VEGF-A X ANG-2 inhibitorTopline Phase 2a data show VIS-101 provides rapid, robust and durable ...
In a unique class hosted at the Smithsonian Conservation Biology Institute, early-career ecologists learned to apply emerging ...
Agents can now send brokerage listing data directly into Canva, bridging the gap between property data and content ...
Alume Biosciences delivers positive topline results for three pivotal trials of Bevonescein, advancing toward NDA submission with US FDA in 2H 2026 Even with meticulous technique, surgeons are limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results